Zacks Investment Research Upgrades Kirin (KNBWY) to Hold

Zacks Investment Research upgraded shares of Kirin (OTCMKTS:KNBWY) from a strong sell rating to a hold rating in a research report report published on Wednesday morning.

According to Zacks, “Kirin Holdings Company, Limited is engaged in the manufacture and sale of alcohol beverages and soft drinks. The Company has four segments: Alcohol Beverage segment, Beverage and Food segment, Pharmaceutical and Biochemicals segment and Others segment. It offers beer, wine, ready-to-drink products, spirits, coffee, black tea, Japanese tea, mineral water, juices, dairy products and beverages, seasonings, soft drinks, freeze-dried soups, milk, and cheese. Kirin also engages in the research, development, manufacture and sale of various pharmaceutical products, manufacture and sale of diagnostic reagents, production and maintenance of genetically modified cattle and the research and development of human polyclonal antibody platform technology. Kirin Holdings Company, Limited, formerly known as Kirin Brewery Company, is headquartered in Tokyo, Japan. “

Separately, ValuEngine lowered Kirin from a buy rating to a hold rating in a research report on Thursday, July 19th.

Shares of KNBWY stock opened at $24.11 on Wednesday. The company has a current ratio of 1.41, a quick ratio of 1.09 and a debt-to-equity ratio of 0.30. Kirin has a fifty-two week low of $22.58 and a fifty-two week high of $30.08. The stock has a market capitalization of $23.44 billion, a price-to-earnings ratio of 15.66, a PEG ratio of 1.85 and a beta of 0.17.

Kirin (OTCMKTS:KNBWY) last issued its earnings results on Tuesday, August 7th. The company reported $0.37 earnings per share for the quarter. The firm had revenue of $8.42 billion during the quarter. Equities research analysts expect that Kirin will post 1.39 earnings per share for the current fiscal year.

About Kirin

Kirin Holdings Company, Limited manufactures and sells alcoholic and non-alcoholic beverages, and pharmaceuticals and bio-chemicals in Japan and internationally. It operates through four segments: Japan Integrated Beverages Business, Oceania Integrated Beverages Business, Other Overseas Integrated Beverages Business, and Pharmaceuticals and Bio-chemicals Business.

Recommended Story: Do You Need a Fiduciary?

Get a free copy of the Zacks research report on Kirin (KNBWY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kirin and related companies with's FREE daily email newsletter.

Leave a Reply